In a recent corporate action, SBP GROUP (01177) has announced the cancellation of a significant number of its own shares. The company confirmed that on June 4, 2026, it formally extinguished 40.35 million shares that had been previously repurchased.

This move effectively reduces the total number of shares in circulation for the pharmaceutical company. The cancellation of these repurchased shares is a common corporate finance procedure following a buyback program.